398 related articles for article (PubMed ID: 25740811)
1. Epstein-Barr virus in inflammatory bowel disease: the spectrum of intestinal lymphoproliferative disorders.
Nissen LH; Nagtegaal ID; de Jong DJ; Kievit W; Derikx LA; Groenen PJ; van Krieken JH; Hoentjen F
J Crohns Colitis; 2015 May; 9(5):398-403. PubMed ID: 25740811
[TBL] [Abstract][Full Text] [Related]
2. Human cytomegalovirus and Epstein-Barr virus infection in inflammatory bowel disease: need for mucosal viral load measurement.
Ciccocioppo R; Racca F; Paolucci S; Campanini G; Pozzi L; Betti E; Riboni R; Vanoli A; Baldanti F; Corazza GR
World J Gastroenterol; 2015 Feb; 21(6):1915-26. PubMed ID: 25684960
[TBL] [Abstract][Full Text] [Related]
3. EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder.
Hart M; Thakral B; Yohe S; Balfour HH; Singh C; Spears M; McKenna RW
Am J Surg Pathol; 2014 Nov; 38(11):1522-9. PubMed ID: 25007145
[TBL] [Abstract][Full Text] [Related]
4. Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients.
Lee TC; Savoldo B; Barshes NR; Rooney CM; Heslop HE; Gee AP; Caldwell Y; Scott JD; Goss JA
Clin Transplant; 2006; 20(3):389-93. PubMed ID: 16824159
[TBL] [Abstract][Full Text] [Related]
5. Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease.
Smets F; Latinne D; Bazin H; Reding R; Otte JB; Buts JP; Sokal EM
Transplantation; 2002 May; 73(10):1603-10. PubMed ID: 12042647
[TBL] [Abstract][Full Text] [Related]
6. Refractory inflammatory bowel disease: is there a role for Epstein-Barr virus? A case-controlled study using highly sensitive Epstein-Barr virus-encoded small RNA1 in situ hybridization.
Pezhouh MK; Miller JA; Sharma R; Borzik D; Eze O; Waters K; Westerhoff MA; Parian AM; Lazarev MG; Voltaggio L
Hum Pathol; 2018 Dec; 82():187-192. PubMed ID: 30120969
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus infection in colorectal neoplasms associated with inflammatory bowel disease: detection of the virus in lymphomas but not in adenocarcinomas.
Wong NA; Herbst H; Herrmann K; Kirchner T; Krajewski AS; Moorghen M; Niedobitek F; Rooney N; Shepherd NA; Niedobitek G
J Pathol; 2003 Oct; 201(2):312-8. PubMed ID: 14517849
[TBL] [Abstract][Full Text] [Related]
8. Impact of Epstein-Barr virus infection on inflammatory bowel disease (IBD) clinical outcomes.
Núñez Ortiz A; Rojas Feria M; de la Cruz Ramírez MD; Gómez Izquierdo L; Trigo Salado C; Herrera Justiniano JM; Leo Carnerero E
Rev Esp Enferm Dig; 2022 May; 114(5):259-265. PubMed ID: 34315215
[TBL] [Abstract][Full Text] [Related]
9. Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction.
Omar H; Hägglund H; Gustafsson-Jernberg A; LeBlanc K; Mattsson J; Remberger M; Ringdén O; Sparrelid E; Sundin M; Winiarski J; Yun Z; Ljungman P
Transpl Infect Dis; 2009 Oct; 11(5):393-9. PubMed ID: 19497070
[TBL] [Abstract][Full Text] [Related]
10. The Status of Epstein-Barr Virus Infection in Intestinal Mucosa of Chinese Patients with Inflammatory Bowel Disease.
Li X; Chen N; You P; Peng T; Chen G; Wang J; Li J; Liu Y
Digestion; 2019; 99(2):126-132. PubMed ID: 30235444
[TBL] [Abstract][Full Text] [Related]
11. Comparison of six different specimen types for Epstein-Barr viral load quantification in peripheral blood of pediatric patients after heart transplantation or after allogeneic hematopoietic stem cell transplantation.
Ruf S; Behnke-Hall K; Gruhn B; Bauer J; Horn M; Beck J; Reiter A; Wagner HJ
J Clin Virol; 2012 Mar; 53(3):186-94. PubMed ID: 22182950
[TBL] [Abstract][Full Text] [Related]
12. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
[TBL] [Abstract][Full Text] [Related]
13. Looking into Enteric Virome in Patients with IBD: Defining Guilty or Innocence?
Lopes S; Andrade P; Conde S; Liberal R; Dias CC; Fernandes S; Pinheiro J; Simões JS; Carneiro F; Magro F; Macedo G
Inflamm Bowel Dis; 2017 Aug; 23(8):1278-1284. PubMed ID: 28617757
[TBL] [Abstract][Full Text] [Related]
14. Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease).
Ruther U; Nunnensiek C; Muller HA; Bader H; May U; Jipp P
Hepatogastroenterology; 1998; 45(21):691-9. PubMed ID: 9684118
[TBL] [Abstract][Full Text] [Related]
15. Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study.
Johnson LR; Nalesnik MA; Swerdlow SH
Am J Surg Pathol; 2006 Dec; 30(12):1604-12. PubMed ID: 17122518
[TBL] [Abstract][Full Text] [Related]
16. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].
Merlino C; Giacchino F; Bergallo M; Bonello F; Bollero C; Segoloni GP; Cavallo R
G Ital Nefrol; 2003; 20(2):170-5. PubMed ID: 12746803
[TBL] [Abstract][Full Text] [Related]
17. Surveillance of Epstein-Barr virus loads in adult liver transplantation: associations with age, sex, posttransplant times, and transplant indications.
Schaffer K; Hassan J; Staines A; Coughlan S; Holder P; Tuite G; McCormick AP; Traynor O; Hall WW; Connell J
Liver Transpl; 2011 Dec; 17(12):1420-6. PubMed ID: 21837744
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of Epstein-Barr Virus, Cytomegalovirus, and Polyomaviruses in Children with Inflammatory Bowel Disease.
Hradsky O; Copova I; Zarubova K; Durilova M; Nevoral J; Maminak M; Hubacek P; Bronsky J
Dig Dis Sci; 2015 Nov; 60(11):3399-407. PubMed ID: 26091801
[TBL] [Abstract][Full Text] [Related]
19. EBV-positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in the posttransplant setting: a distinct type of posttransplant lymphoproliferative disorder?
Gibson SE; Swerdlow SH; Craig FE; Surti U; Cook JR; Nalesnik MA; Lowe C; Wood KM; Bacon CM
Am J Surg Pathol; 2011 Jun; 35(6):807-15. PubMed ID: 21552113
[TBL] [Abstract][Full Text] [Related]
20. Soluble CD30: a serum marker for Epstein-Barr virus-associated lymphoproliferative diseases.
Haque T; Chaggar T; Schafers J; Atkinson C; McAulay KA; Crawford DH
J Med Virol; 2011 Feb; 83(2):311-6. PubMed ID: 21181928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
